• No results found

18 results with keyword: 'clinical prognostic significance evi expression acute myeloid leukaemia'

Exploitation of some raw minerals for Increasing productivity of ordinary portland cement.

(CaAl 2 Si 2 O 8 .4H 2 O), hydrated calcium silicate (Ca 1. 3) The decrease in the intensity of the peaks of the anhydrous minerals and increase in the intensity of the peaks

Protected

N/A

23
0
0
2020
Clinical and Prognostic Significance of EVI1 Expression in Acute Myeloid Leukaemia

Visoka ekspresija EVI1 gena je faktor loše prognoze kod obolelih od akutne mijeloidne leukemije i u kombinaciji sa drugim prognostičkim markerima, doprinosi boljoj

Protected

N/A

123
0
0
2021
LIFELONG LEARNING PROGRAMME LDV PARTNERSHIP IMPROVING EMPLOYMENT OPPORTUNITIES IN THE LABOUR MARKET MARGINALISED COMMUNITIES

During this mobility Partners visited Vocational Activisation Centre (CAZ) operating within the Poviat Labour Office in Wroclaw, where they were briefed on the activities

Protected

N/A

35
0
0
2021
REVIEW ARTICLE Recent advances in diagnostic and prognostic aspects of acute myeloid leukaemia

Prognostic Significance of CEBPA Mutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukaemia: Impact of Double CEBPA Mutations and the Interaction With

Protected

N/A

8
0
0
2020
Clinical Implication of CD33 or CD34 Expression in Childhood Acute Leukemia

Clinical importance of myeloid antigen expression in adult acute lymph- oblastic leukemia.. Myeloid-associated antigen ex- pression lacks prognostic value in childhood

Protected

N/A

7
0
0
2021
Quantitative Assessment of WT1 Expression by Real Time Quantitative PCR in Pediatric Patients with Acute Myeloblastic Leukemia

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk

Protected

N/A

7
0
0
2020
The prognostic significance of the mixed lineage leukaemia partial tandem duplication in acute myeloid leukaemia

Early identification o f unresponsive and relapsing patients using molecular MRD status would give the clinician time to make pro-active changes in the treatment

Protected

N/A

356
0
0
2021
A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high- risk

Protected

N/A

12
0
0
2020
Analysis of gene rearrangements and protein expression of the tumour suppressor genes, RB1 and p16, in acute myeloid leukaemia: Possible roles in leukaemogenesis

ANALYSIS OF PROTEIN EXPRESSION OF THE RETINOBLASTOMA GENE IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA.. 4.1

Protected

N/A

209
0
0
2020
Prognostic significance of the  PANK  family expression in acute myeloid leukemia

Results: Patients with high PANK2 expression had significantly longer event-free survival (EFS) and overall survival (OS) than patients with low PANK2 expression (P=0.007,

Protected

N/A

9
0
0
2020
Significance of cytogenetic abnormalities in acute myeloid leukaemia

Keeping in view the diagnostic and prognostic sig- nificance of cytogenetic abnormalities, we report cytogenet- ic findings in 52 AML patients seen at our institution from January

Protected

N/A

7
0
0
2021
Leukaemia and Lymphoma Monitoring the care of leukaemia and lymphoma patients in Northern Ireland diagnosed in 2008

In 2008 there were 73 adult* patients with a new diagnosis of acute lymphoblastic leukaemia, acute myeloid leukaemia or chronic myeloid leukaemia in Northern Ireland (Table 4)..

Protected

N/A

112
0
0
2021
Acute myeloid leukaemia

Intensive consolidation chemotherapy (ICC) vs purged autologous bone marrow transplantation (ABMT) early in remission for treatment of childhood acute myeloid leukaemia

Protected

N/A

14
0
0
2021
BECOME SOMETHING MORE.

The insurance carrier creates, registers and underwrites the insurance product and the FMO distributes and wholesales the products to independent insurance producers and

Protected

N/A

16
0
0
2021
ROLE OF AYURVEDAIN MANAGEMENT OF LEUKEMIA (RAKTARBUDA)

Acute leukaemia may be derived from the myeloid stem cells called acute myeloblastic leukaemia (AML), or from the lymphoid stem cells termed acute lymphoblastic

Protected

N/A

11
0
0
2020
Comparing antibody and small-molecule therapies for cancer

AML, acute myeloid leukaemia; CLL, chronic lymphocytic leukaemia; CML, chronic myeloid leukaemia; CRC, colorectal cancer; EGFR, epidermal growth factor receptor; FLT3,

Protected

N/A

14
0
0
2021
Development And Analysis Of Face Recognition System On A Mobile Robot Environment

Secondly having the ability of face recognition would enable the camera to keep a log of all those whom the robot have came in contact with alongside with the time place and

Protected

N/A

24
0
0
2019
Central nervous system leukemia in childhood and adolescent acute lymphoblastic leukemia: How to prevent? How to treat?

Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation:

Protected

N/A

9
0
0
2021

Upload more documents and download any material studies right away!